Life science campuses of yesteryear' tended to be remote, all-work-no-play settings Today's versions are city-centered and ...

It’s no longer a question if these companies will grow; it’s about how and where they choose to grow to offer flexibility, manage risk and support long-term stability.

W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...

The data flowing through our hiring platform reveals a market that is no longer just ‘hiring for headcount’—it is hiring for pipeline certainty.

Coriolis Pharma's new facility will let the company work directly with North American clients to develop and analyze biotech ...

Caris projects 2026 total revenue in the range of $1.0 billion to $1.02 billion, anticipating molecular profiling growth of approximately 21% to 22%, and therapy selection volume growth of around 20% ...

The country’s life sciences sector will likely continue to see staggered binary fission as investors pull back and vacancies remain high. But, in a way, the asset class will be normalizing from a ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...

The city has a higher share of vacant life science space than any other part of the country due to a slowdown in venture capital funding, exposing challenges in the local industry that could worsen as ...

PROVIDENCE, R.I. (WPRI) — The Rhode Island Life Science Hub has named Dr. Mark Turco to be its first president and CEO. “With a top-tier board, the launch of an incubator lab and other programs, and ...

Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to ...